Priothera

About Priothera

Priothera is dedicated to extending and enhancing the quality of life for patients with hematological malignancies by developing innovative therapies. Their mission is to transform treatment outcomes through immune modulators that improve the curative potential of allogeneic hematopoietic cell transplantation (allo-HCT) and CAR T cell therapy, aiming for safer and more effective long-term results.

Products & Services

Mocravimod:An investigational drug designed to enhance the graft-versus-leukemia (GvL) effect while reducing graft-versus-host disease (GvHD) in allogeneic hematopoietic cell transplantation (allo-HCT) for hematological malignancies.

CAR T Cell Therapy Solutions:Innovative approaches to enhance outcomes in CAR T cell therapy for patients with blood cancers.

Hematopoietic Cell Transplantation (HCT) Therapies:Therapies aimed at improving survival and quality of life for patients undergoing HCT, particularly for acute myeloid leukemia (AML).

Specialties

Hematological Malignancies Immune Modulators Allogeneic Hematopoietic Cell Transplantation (allo-HCT) CAR T Cell Therapy Graft-versus-Leukemia (GvL) Effect Graft-versus-Host Disease (GvHD) Reduction

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Non-dilutive Grant T: - FT: Non-dilutive Grant	A: 1870000 MR: - FA: €1.7 million FAN: 1870000	D: 2025-06-24 FD: 2025-06-24	1 investors

Non-dilutive Grant Latest

2025-06-24

$1.9M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Christoph Bucher

Head of Clinical Advisory Board and Founder

S

Simone Seiter

Head of Commericial, Chair of Scientific Advisory Board, and Founder

M

M. De Lima

Director of the Blood and Bone Marrow Transplant and Cellular Therapy Program and Professor in the Division of Hematology

M

M. Mohty

Professor

F

Florent Gros

Chief Executive Officer and Founder

S

Stephan Oehen

Chief Operating Officer and Founder

View 17 more team members with Pro

Unlock Full Team Directory

Recent News

Priothera Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised